Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Single-blinded and Parallel Study to Assess the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults

NCT04940845 is registered in ClinicalTrials.gov with Shanghai Hansoh Biomedical Co., Ltd as lead sponsor.

NCT NCT04940845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04940845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Single-blinded and Parallel Study to Assess the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults
Lead sponsor
Shanghai Hansoh Biomedical Co., Ltd
Phase
Phase 1
Overall status
Unknown status
Start date
July 26, 2021
Completion date
June 30, 2022
Enrollment
174 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis